nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Published on by Top Pharmaceutical

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Dr. nisreen kaddim, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nisreen Kaddim Radi is an Assistant Professor at the University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🧬. Her research focuses on antimicrobial resistance, food safety, and innovative antibacterial films for medical applications 🏥. She has presented at international conferences and published extensively in high-impact journals 📚. Passionate about advancing science, she integrates computational and experimental approaches to explore anticancer and antibacterial agents ⚗️. With a commitment to research and education, Dr. Nisreen inspires students and contributes to scientific innovation 🌍.

Publication Profile

Google Scholar

Professional Background

Dr. Nisreen Kaddim Radi 🎓 is an Assistant Professor at the College of Science for Women, University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🦠, with a focus on food safety and packaging 🍱. She is a member of the Arab Association for Science and Technology, Iraq branch, and serves on the Educational Guidance Committee at her college. Dr. Nisreen has published numerous research papers and actively participates in global conferences 🌍, including the 2022 International Conference on Sustainable Development Goals in Istanbul, ICAB 2022 at the University of Basrah, and ICAB2 2024, where she presented her studies on antimicrobial resistance, genetic variation, and immunological research

Memberships

Dr. Nisreen Kaddim Radi 🔬 is a dedicated researcher with significant contributions to molecular biology, genetics, and virology 🧬. Although she does not hold editorial positions or industry collaborations, her active engagement in scientific research strengthens her impact in the field. As a member of the Arab Association for Science and Technology 🌍, she remains connected to a network of experts, enhancing her academic and professional credibility. Through her research and participation in international conferences, Dr. Nisreen continues to contribute valuable insights to the scientific community, particularly in food safety and antimicrobial resistance 🦠.

Innovation in Methodology

Dr. Nisreen Kaddim Radi 🔬 combines computational simulations with experimental studies to develop innovative methods for enhancing the effectiveness of antibacterial and anticancer agents 🦠🎗️. Her dual-approach methodology integrates cutting-edge technology with practical applications, demonstrating a high level of scientific innovation 🚀. By bridging computational modeling with real-world experimentation, she contributes to advancing medical and pharmaceutical research, aligning perfectly with the award’s objectives 🏆. Her work not only improves therapeutic outcomes but also paves the way for more efficient and targeted treatments, reinforcing her role as a leading researcher in molecular biology and biotechnology 🧬.

Research Excellence

Dr. Nisreen Kaddim Radi 🔬 is pioneering the development of antibacterial films by integrating nanomaterials, polymers, and plant extracts 🌱🦠. Her innovative approach has profound implications for both medical and industrial applications 🏥🏭, positioning her at the forefront of antibacterial and anticancer material research 🎗️. Her groundbreaking study, Integrative Computational and Experimental Study of Propolis, Polyvinyl Alcohol, and Alhagi maurorum Complex as Anticancer and Antibacterial Agents 📜, showcases a multidisciplinary methodology, blending computational modeling with experimental validation 💻⚗️. This research enhances therapeutic potential, contributing to the advancement of novel biomedical materials and precision-targeted treatments 🚀.

Research Focus

Dr. Nisreen Kaddim Radi’s research primarily focuses on medical microbiology 🦠, immunology 🧬, and infectious diseases 🏥. Her work extensively explores viral infections such as Varicella Zoster Virus (VZV) 🏵️, Human Papillomavirus (HPV) 🎗️, and Hepatitis B Virus (HBV) 🦠, investigating genetic susceptibility and immune response. She also examines bacterial resistance 🧫, particularly in foodborne pathogens like E. coli, and studies immunological markers 🧪 in various infections. Her contributions in genetic polymorphisms 🔬, cytokine responses 🌡️, and molecular typing of pathogens highlight her expertise in understanding disease mechanisms and improving diagnostic approaches in infectious diseases and immunological disorders.

Publication Top Notes

Investigation of oxidative stress in patient with Varicella Zoster Virus (VZV) infection

Human genetic variation susceptibility associated with HBV: analysis of genetic markers susceptibility to hepatitis b among patients in babylon province

Genetic study of TORCH infections in women with bad obstetric history: multiplex polymerase chain reaction for detection of common pathogens and agents of congenital infections

Evaluation of CD4 and CD8 in Patients Infected with Genital Wart Caused by Human Papilloma Virus in Babylon Province/Iraq

Evaluation of serum IgE, TNF alpha at patients with genital warts, Iraq.

Immunological Study for Patient with Verruca Vulgaris and Verruca Plana Caused by HPV in Hilla/Iraq

The effect of manganese poisoning on the histological structure of testis in male Swiss mice

Bacteriological Study of Tonsillitis Patients and Estimation of Concentrations of Certain Immunological Parameters.

The distribution of antimicrobial resistance and the presence of virulence genes in Escherichia coli isolated from frozen chicken meat in Iraq

Sajid Ali | Nanomedicine | Excellence in Research

Published on by Top Pharmaceutical

Sajid Ali | Nanomedicine | Excellence in Research

Dr Sajid Ali, Quaid I azam university Islamabad, Pakistan

Dr. Sajid Ali, a dedicated pharmacist from Pakistan, holds a PharmD (CGPA 3.8/4) and an MPhil in Pharmaceutics (CGPA 3.9) from Quaid-i-Azam University, Islamabad. With experience as a lab demonstrator and pharmacist, he excels in pharmaceutical sciences, including HPLC, UV spectroscopy, and GMP implementation. Dr. Ali’s research on green-synthesized zinc oxide nanoparticles for wound management was published in Microbial Pathogenesis. Passionate about global healthcare, he has also completed numerous certifications, including antimicrobial resistance and pharmaceutical innovations. Dr. Ali’s multilingual abilities, extracurricular contributions, and drive for innovation position him as a transformative force in healthcare. 💊🌍

Education

Dr. Sajid Ali is currently pursuing an MPhil in Pharmaceutics at Quaid-i-Azam University, Islamabad 🏛️, a prestigious institution known for its excellence in research and education 🌟. He began this advanced academic journey on September 1, 2023, and continues to deepen his expertise in the field of pharmaceutics 💊. Previously, Dr. Sajid completed his Doctor of Pharmacy (Pharm.D) degree at the same university 🎓, spanning from September 2018 to September 2023. With a strong foundation in pharmacy and a passion for innovation in healthcare 🌱, Dr. Sajid aspires to make significant contributions to the pharmaceutical sciences. 🌟

Work Experience

Dr. Sajid Ali, a dedicated pharmacist from Pakistan 🎓🇵🇰, has a robust professional journey spanning academia, community pharmacy, and industry. As a Lab Demonstrator at Quaid-i-Azam University (Sept 2024–Mar 2025) 📚🧪, he guided students in using advanced pharmaceutical instruments like HPLC and FTIR while honing their analytical skills. Currently, as a Pharmacist at Al Shifa Pharmacy in Rawalpindi (Sept 2024–Present) 💊👩‍⚕️, he ensures accurate medication dispensing, patient counseling, and inventory management. His prior role as an Industrial Pharmacist at Glitz Pharmaceutical (July–Aug 2023) 🏭🔬 focused on R&D, quality control, and GMP compliance. Sajid’s journey began at Siddique Homeo Clinic (2018–2022) 🌿🤝, where he excelled in patient counseling and multitasking.

Online Courses

Dr. Sajid Ali has an impressive record of completing various online courses, showcasing his dedication to continuous learning 🌟. He gained expertise in International Business through a course at the University of New Mexico, covering exporting goods, joint ventures, and branch distribution 🌍. During the pandemic, he enriched his knowledge with COVID-19 – A Clinical Update from the University of Florida 🦠. Dr. Ali also explored Cancer Biology at Johns Hopkins University 🔬, clinical terminology at the University of Pittsburgh 🏥, and Pharmaceutical Innovations at the University of Minnesota 💊. Additionally, he completed an Antimicrobial Resistance course at the Technical University of Denmark 🧪.

Volunteer Experience

Dr. Sajid Ali has been actively contributing to the Pakistan Polio Eradication Programme under WHO, conducting numerous Lot Quality Assurance Sampling (LQAS) during the August 2023 National Immunization Day (NID) campaign 📊. He collected vital household data through handheld devices in targeted areas of Rawalpindi, ensuring data accuracy and quality 🔍. Additionally, Dr. Sajid received a prestigious certificate in Quality Considerations for Aseptic Processing from the United States Pharmacopoeia Education in December 2022 🧪. He also earned a certificate for participating in the Chinese Bridge: Travel with Tang Poetry online program, fostering cross-cultural learning, sponsored by China’s Ministry of Education 🌏📜.

Research Focus

Dr. Sajid Ali focuses on nanotechnology in biomedical applications, particularly in developing green-synthesized nanoparticles for wound management. His research bridges nanotechnology 🧪, drug delivery systems 💊, and antimicrobial therapies 🦠 to improve healing processes 🩹. By utilizing environmentally friendly methods 🌱, Dr. Ali innovates solutions for antibiotic delivery and enhanced tissue repair. His work contributes to sustainable medical technologies, showcasing a dual impact on infection control and wound care. Dr. Ali’s groundbreaking research highlights the intersection of nanomedicine and green chemistry, fostering advancements in healthcare innovation 🚑.

Publication Top Notes

Harnessing Green Synthesized Zinc Oxide Nanoparticles for Dual Action in Wound Management: Antibiotic Delivery and Healing Promotion

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy